Poliovirus is a small, non-enveloped RNA virus that belongs to the enterovirus genus and is the causative agent of poliomyelitis, a disease that can destroy motor neurons in the spinal cord and brainstem, leading to irreversible paralysis. Despite decades of global vaccination efforts that have reduced wild poliovirus cases by more than 99%, the virus has not been fully eradicated. Its biology turns out to be more intricate than early researchers imagined, and the vaccines designed to stop it have introduced their own set of complications that continue to shape public health strategy today.
How Poliovirus Gets Inside a Cell
Poliovirus latches onto a protein on the surface of human cells called CD155, sometimes referred to as the poliovirus receptor. CD155 sits on many cell types, but its presence on motor neurons in the spinal cord is what makes the virus dangerous. The receptor binds in a groove on the virus’s outer shell known as the “canyon,” a feature poliovirus shares with related viruses like human rhinoviruses, which use a similar docking site for their own receptor.1PubMed. Interaction of the poliovirus receptor with poliovirus
What happens next is a carefully choreographed structural collapse. At body temperature, CD155 pushes deeper into the canyon, which ejects a small fatty molecule (called the “pocket factor”) wedged inside the shell. Losing this molecular plug destabilizes the whole structure. The virus particle swells from a compact 160S form into a looser 135S particle, and two normally buried proteins swing outward and insert themselves into the cell’s membrane like tiny anchors.2PubMed Central. Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry Those anchors form a pore through which the virus threads its RNA genome directly into the cell’s interior.3PubMed Central. Crystal structure of CD155 and electron microscopic studies of its complexes with polioviruses The whole process is irreversible: once the receptor triggers the expansion, the virus cannot reassemble. It is a one-shot mechanism, which means every virus particle that attaches to a cell either succeeds in injecting its RNA or is destroyed in the attempt.
From the Gut to the Nervous System
Poliovirus is an oral infection. You swallow it, usually through contaminated water or food, and it begins replicating in the lining of the throat and intestines. A primate model of oral infection showed that the virus replicates in two distinct cell populations early on: epithelial cells in the gut (which explains why infected people shed large quantities of virus in their stool) and immune cells in lymphoid tissue like the tonsils and Peyer’s patches, the immune surveillance stations scattered along the intestinal wall.4PubMed Central. Pathogenic Events in a Nonhuman Primate Model of Oral Poliovirus Infection Leading to Paralytic Poliomyelitis Replication in lymphoid tissue is what allows virus to spill into the bloodstream, a stage called viremia.
For the vast majority of people infected, the story ends there. The immune system clears the virus from the blood before it reaches the central nervous system, and the person either has no symptoms at all or experiences a brief flu-like illness. Paralytic disease develops in fewer than one in a hundred infections. But when the virus does breach the nervous system, the consequences are severe.
How the Virus Travels Along Nerves
Poliovirus can reach motor neurons by crossing from the blood into the spinal cord, but there is also evidence that it travels along peripheral nerves themselves. Researchers have tracked individual virus particles moving backward along axons (the long extensions motor neurons use to signal muscles) at speeds consistent with the cell’s own internal transport machinery.5PubMed Central. Retrograde axonal transport of poliovirus and EV71 in motor neurons Intact virus particles were observed traveling from axon tips toward the cell body, hitching a ride on the same molecular motors that normally carry cargo back to the neuron’s nucleus.
This route sounds efficient, but it actually isn’t. In one study that tracked viral populations moving through the sciatic nerve, about 87% of the virus present in muscle tissue made it into the lower portion of the nerve. But only 28% of those variants survived transport from the lower nerve to the upper nerve. Most particles were lost along the way.6PLoS Pathogens. Limited Trafficking of a Neurotropic Virus Through Inefficient Retrograde Axonal Transport and the Type I Interferon Response The inefficiency of this bottleneck, combined with the interferon response that neurons mount against infection, helps explain why paralysis is rare relative to how common poliovirus infection actually is. Most of the time, the virus simply cannot get enough particles into the spinal cord to cause significant damage.
Why Paralysis Happens
When poliovirus does reach the spinal cord in sufficient numbers, it targets a specific group of cells: the anterior horn motor neurons, the large nerve cells that send signals from the spinal cord to skeletal muscles. The virus replicates inside these neurons and kills them. Because motor neurons do not regenerate, the muscles they controlled lose their nerve supply permanently. The result is flaccid paralysis, meaning the affected muscles go limp rather than stiff.7PubMed. The neuropathology observed in wild-type mice inoculated with human poliovirus mirrors human paralytic poliomyelitis
The pattern of paralysis depends on which motor neurons are destroyed. Leg muscles are affected most often, but the virus can also hit neurons controlling the arms, the trunk, or, in the most dangerous cases, the muscles used for breathing. Before mechanical ventilation was available, bulbar poliomyelitis (affecting the brainstem) was frequently fatal.
Post-Polio Syndrome
Survivors of paralytic polio often experience a second wave of decline decades later. Post-polio syndrome affects roughly 25% to 40% of people who recovered from the original paralytic illness, and it typically surfaces 15 to 40 years after the acute infection.8PubMed Central. Post-Polio Syndrome Revisited Symptoms include new muscle weakness, fatigue, pain, and sometimes difficulty swallowing or breathing.
The mechanism is tied to how the body compensated for the original damage. After polio kills some motor neurons, surviving neighboring neurons sprout extra branches to re-innervate the orphaned muscle fibers. For years or decades, this compensation works well enough that the person regains significant function. But each surviving neuron is now doing the work of several, and over time those overburdened neurons begin to fail. The axonal sprouts break down, muscles lose their nerve supply again, and strength declines.9PubMed. Pathogenetic mechanisms of post-polio syndrome: morphological, electrophysiological, virological, and immunological correlations Post-polio syndrome is not a new infection; it is the long-delayed collapse of a repair system that was always running at its limits.
Why Poliovirus Only Infects Primates
Poliovirus is one of the more host-restricted viruses known. Under natural conditions, it only infects humans and certain other primates. The reason comes down to CD155. The gene encoding this receptor exists across many mammalian species, but the part of the protein the virus actually grabs onto, the outermost immunoglobulin-like domain, has changed rapidly over evolutionary time. In ring-tailed lemurs, the binding domain shares only about 51% of its amino acid sequence with the human version; in rabbits, about 61%. When researchers built hybrid receptors using the binding domain from these species, poliovirus could not use them.10PubMed. Host range of poliovirus is restricted to simians because of a rapid sequence change of the poliovirus receptor gene during evolution
This host restriction is actually important for eradication. Because poliovirus has no animal reservoir, if you can stop it from circulating among humans, it has nowhere to hide. That distinguishes it from viruses like influenza or Ebola, which can persist in animal populations and jump back into humans.
The Evolutionary Origins of Poliovirus
Poliovirus did not emerge from nothing. Genomic analysis places it firmly within a cluster of enteroviruses known as species C, alongside several coxsackievirus A serotypes. Outside the capsid (the protein shell), the poliovirus genome is extremely similar to those of its coxsackievirus relatives, differing by only a few percent in some coding regions. The viruses are monophyletic (sharing a single ancestor) only in the genes that encode their outer shells, while the rest of their genomes tell a tangled story of frequent recombination.11PubMed Central. Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region
The leading hypothesis for how poliovirus became a distinct pathogen is that an ancestral coxsackievirus acquired mutations in its capsid that switched its receptor preference from a different cell-surface protein to CD155.12PubMed Central. Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication That single shift in binding specificity opened the door to motor neuron infection and, with it, the capacity to cause paralysis. Essentially, poliovirus is a coxsackievirus that learned a new trick.
Two Vaccines, Two Different Trade-offs
The global fight against polio has relied on two fundamentally different vaccines. The inactivated poliovirus vaccine (IPV), developed by Jonas Salk, uses virus killed with formaldehyde. It produces strong antibodies in the blood that prevent the virus from reaching the nervous system, but it generates weaker immunity in the gut lining. The oral poliovirus vaccine (OPV), developed by Albert Sabin, uses live virus that has been weakened (attenuated) so it replicates harmlessly in the intestine. OPV triggers a robust immune response both in the blood and in the gut mucosa, which means vaccinated individuals are less likely to shed the virus and spread it to others.
That mucosal advantage made OPV the workhorse of mass vaccination campaigns, especially in low-income settings where fecal-oral transmission drives polio spread. However, IPV’s weaker gut immunity means that someone vaccinated only with IPV can still become intestinally infected with poliovirus and shed it in their stool, even though they themselves are protected from paralysis. This distinction matters enormously for eradication strategy, because silent intestinal infections can sustain virus circulation in a community even when paralytic cases have disappeared.
The Vaccine-Derived Poliovirus Problem
The same feature that makes OPV effective, a live virus replicating in the gut, also creates a serious complication. The attenuated Sabin strains can mutate as they replicate, and the mutations that made them safe can revert. Studies in Nigeria showed that reversion at key genetic sites can happen within days to weeks after vaccination.13PubMed Central. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria Analysis of virus shed by vaccinated individuals found that a majority of samples from all three OPV strains had already reverted at their most important attenuating site by the time they were collected.14npj Vaccines. Rapid emergence and transmission of virulence-associated mutations in the oral poliovirus vaccine following vaccination campaigns
In populations with low vaccination coverage, these reverted viruses can circulate from person to person, accumulating further mutations and recombining with related enteroviruses until they regain the ability to cause paralysis. These are called circulating vaccine-derived polioviruses, and they have caused hundreds of paralytic cases in recent years. People with weakened immune systems are especially vulnerable because they can shed the vaccine virus for months or years, giving the virus time to evolve extensively. In such patients, researchers have documented reversion of neurovirulence mutations and recombination between different vaccine strains.15PubMed. Reversion of neurovirulent mutations, recombination and high intra-host diversity in vaccine-derived poliovirus excreted by patients with primary immune deficiency
The paradox is sharp: the very tool that brought the world closest to eradication is now responsible for the majority of new polio cases. In many recent years, more children have been paralyzed by vaccine-derived poliovirus than by the wild virus itself.
A Redesigned Oral Vaccine
To break this cycle, researchers developed a novel oral poliovirus vaccine type 2 (nOPV2) with engineered genetic modifications designed to make reversion much harder. The key attenuating mutations in the original Sabin strain sit at single nucleotide positions that can flip back with a single copying error. The nOPV2 design relocated and reinforced these features so that the virus would need multiple independent changes to regain virulence.16PubMed Central. Higher stability of novel live-attenuated oral poliovirus type 2 (nOPV2) despite the emergence of a neurovirulent double recombinant strain in Uganda
Clinical trials comparing virus shed by infants who received nOPV2 versus the original Sabin type 2 found a dramatic difference. In mouse models used to test neurovirulence, the shed Sabin-2 virus caused paralysis at high rates, while shed nOPV2 virus caused paralysis far less often, with adjusted odds roughly 140 times lower.17The Lancet. Genetic and phenotypic stability of shed novel oral poliovirus vaccine type 2: a comparison of two randomized clinical trials nOPV2 received emergency use authorization from the World Health Organization in 2021 and has since been deployed in outbreak response campaigns across Africa and elsewhere.
The redesign is not a perfect fix. Field surveillance in the Central African Republic found that some nOPV2 derivatives had lost one of their stabilizing genetic domains through recombination with related enteroviruses circulating in the population.18PubMed Central. Emergence of vaccine-derived poliovirus strains from the novel oral polio vaccine in the Central African Republic The genetic drift-driven reversion that nOPV2 was designed to prevent did appear to be curtailed, but recombination, which involves swapping entire chunks of genetic material with co-circulating enteroviruses, remains a path the vaccine virus can exploit. Researchers are watching closely to see whether this recombination route can actually restore full virulence or whether the remaining stabilization features provide a meaningful safety buffer.
Where Wild Poliovirus Still Circulates
Of the three wild poliovirus serotypes, type 2 was last detected in 1999 and officially declared eradicated in 2015. Type 3 has not been seen since 2012. Only wild poliovirus type 1 continues to circulate, and for years it has been confined to Afghanistan and Pakistan.19PubMed Central. Progress of polio eradication and containment requirements after eradication Conflict, political instability, population displacement, and pockets of vaccine refusal in these regions have made the last stretch of eradication extraordinarily difficult.20PubMed. Breaking the Last Chains of Poliovirus Transmission: Progress and Challenges in Global Polio Eradication
Vaccine-derived outbreaks, meanwhile, have appeared in dozens of countries across Africa, the Middle East, and Southeast Asia, sometimes in places that had been free of any poliovirus for years. These outbreaks emerge wherever routine immunization coverage drops low enough to leave a critical mass of unvaccinated children through whom the reverted vaccine virus can spread.
Wastewater Surveillance and Silent Spread
One lesson of recent years is that paralytic cases are an unreliable measure of poliovirus circulation. Because paralysis occurs in fewer than one in a hundred infections, a single case implies hundreds of silent infections in the community. Wastewater surveillance has become a crucial tool for detecting the virus before anyone becomes paralyzed.
In 2022, after a case of paralytic polio was identified in Rockland County, New York, wastewater testing across seven jurisdictions revealed vaccine-derived poliovirus type 2 in sewage samples from multiple New York counties and New York City. The testing identified two genetically distinct viruses, meaning two separate importation events had occurred.21PubMed Central. Wastewater Surveillance for Poliovirus in Selected Jurisdictions, United States, 2022-2023 In New York state alone, 86 sewage samples from four counties tested positive over roughly nine months, all genetically linked to the paralytic case.22Emerging Infectious Diseases. Wastewater Surveillance for Poliovirus in Selected Jurisdictions, United States, 2022–2023 The extent of environmental detection made clear that the virus had been circulating silently in under-vaccinated communities well before the one identified paralysis case brought attention to it.
Containing Poliovirus in Laboratories
Eradication from the wild does not mean eradication from the planet. Poliovirus samples sit in freezers, incubators, and storage vaults in research labs and vaccine production facilities around the world. After eradication, any one of those samples could theoretically restart transmission if it escaped into the community. The World Health Organization has developed a containment framework requiring countries to identify, inventory, and either destroy or secure all poliovirus materials.
In the United States, a national containment program identified 30 facilities in 15 states that retained infectious poliovirus materials as of 2022. After outreach from the national authority for containment, a third of those facilities chose to destroy, inactivate, or transfer their stocks rather than pursue the costly certification process. As of the end of 2022, ten facilities in seven states were still working through certification to continue holding poliovirus under enhanced biosafety conditions.23PubMed Central. Establishment of a Poliovirus Containment Program and Containment Certification Process for Poliovirus-Essential Facilities, United States 2017–2022 – Section: 3. Results / 3.1. Facility Identification and Outreach The containment challenge is global and ongoing: every country that has ever produced or researched poliovirus needs to account for every vial, and the consequences of a single breach could mean reintroduction into an increasingly under-immune population.
Enterovirus D68 and the Shadow of Polio
Poliovirus is not the only enterovirus capable of attacking motor neurons. Enterovirus D68 (EV-D68) drew attention in 2014 and 2016 when outbreaks of respiratory illness in children coincided with spikes in acute flaccid myelitis, a polio-like condition involving paralysis caused by damage to the same anterior horn cells that poliovirus targets. The geographic and temporal overlap, along with the detection of EV-D68 in respiratory samples from affected children, built a circumstantial case for a causal connection, though directly isolating the virus from spinal cord tissue proved elusive.24PubMed Central. Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality
EV-D68 is a reminder that the enterovirus family contains other members with the potential to damage the nervous system. Poliovirus’s unique danger was always partly a matter of scale: it circulated so efficiently and infected so many people that even a rare complication produced epidemics of paralysis. If another enterovirus were to achieve similar levels of transmission and neurotropism, the public health consequences could echo those of polio’s worst years, and no vaccine currently exists for EV-D68.